Harvard Apparatus Regenerative Technology Investor Relations Material
Latest events
Q3 2023
Harvard Apparatus Regenerative Technology
Q1 2025
13 May, 2025
Q4 2024
30 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Harvard Apparatus Regenerative Technology Inc
Access all reports
Harvard Apparatus Regenerative Technology Inc is a U.S.-based biotechnology company developing regenerative medicine solutions. The company focuses on bioengineered implants for airway reconstruction using scaffold and cell technologies. Its research is aimed at treating life-threatening conditions such as tracheal damage and lung diseases. The company is headquartered in Holliston, Massachusetts, and its shares are listed on the OTCQB.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
HRGN
Country
🇺🇸 United States